Cardiovascular disease in Canada
Dagenais, G.R.
Canadian Journal of Cardiology 9(3): 209-211
1993
ISSN/ISBN: 0828-282X PMID: 8508326 Document Number: 412798
Document emailed within 1 workday
Related Documents
Davies, J.W.; Semenciw, R.M.; Mao, Y. 1988: Cardiovascular disease mortality trends and related risk factors in Canada Canadian Journal of Cardiology 4 Suppl A: 16a-20a1995: Collaborative cardiovascular clinical trials in Canada. The Canadian Cardiovascular Collaboration Canadian Journal of Cardiology 11(8): 649-657
Dupont, L.; Lemarchand, N. 1997: La fin du Canada français et la mise en place du Canada moderne - The dissapearance of French Canada and the construction of a modern Canada Hommes et Terres du Nord (3-4): 201-206
Wagner, M.; Goetghebeur, M.; Merikle, E.; Pandya, A.; Chu, P.; Taylor, D.C.A. 2009: Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada Canadian Journal of Clinical Pharmacology 16(2): E331-E345
Stephens, T.; Craig, C.L.; Ferris, B.F. 1986: Adult physical activity in Canada: findings from the Canada fitness survey I and II Activite physique des adultes au Canada: resultats de l'enquete condition physique Canada I et II Revue Canadienne de Sante Publique 77(4): 285-295
Smith, E.R. 2003: A cardiovascular atlas for Canada Canadian Journal of Cardiology 19(7): 854-855
Anand, S.S.; Yusuf, S.; Vuksan, V.; Devanesen, S.; Teo, K.K.; Montague, P.A.; Kelemen, L.; Yi, C.; Lonn, E.; Gerstein, H.; Hegele, R.A. 2000: Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE) Indian Heart Journal 52(7 Suppl): S35-S43
Smith, E.R. 1992: The status of cardiovascular research funding in Canada Canadian Journal of Cardiology 8(2): 106
Raphael, D. 2001: Cardiovascular health in Canada: are we fiddling while Rome is burning? Canadian Journal of Public Health 92(6): 441-442
Schrager, S.; Dalby, J.; Hayon, R.; Fox, K. 2013: Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease Fp Essentials 411: 28-33
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
1997: A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society Canadian Journal of Cardiology 13(1): 33-45
Thorogood, M. 1993: Anticonceptivos orales y enfermedad cardiovascular - Oral contraceptives and cardiovascular disease Beneficios y Riesgos de la Anticoncepcion Oral. Simposio (Caracas 1992-11) 9: 19-29
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Jackevicius, C.A.; Tu, K.; Filate, W.A.; Brien, S.E.; Tu, J.V. 2003: Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001 Canadian Journal of Cardiology 19(12): 1359-1366
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Wong, L.L. 1995: Chinese capitalist migration to Canada: a sociological interpretation and its effect on Canada Asian and Pacific Migration Journal: Apmj 4(4): 465-492
Fugere, P. 1984: Les stèrilets: état actuel au Canada - Current status of IVD's in Canada Union Medicale du Canada 113(6): 538-539
Burkman, R.T. 1994: Noncontraceptive effects of hormonal contraceptives: Bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1569-1575